Skip to content

Integrating Psychotropic Medication Into the Care of People With Mental Disorders in a Prayer Camp in Ghana

Joining Forces: Integrating Psychotropic Medication Into the Care of People With Mental Disorders in a Prayer Camp in Ghana

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02593734
Acronym
JFR
Enrollment
139
Registered
2015-11-02
Start date
2013-07-31
Completion date
2015-07-31
Last updated
2015-11-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety Disorder, Mood Disorders,, Schizophrenia

Brief summary

The purpose of this study is to evaluate a bundled intervention of psychotropic drugs and daily contact with a nurse for people with mental health disorders in a prayer camp and secondly to assess whether the attitudes of the prayer camp staff toward mental health disorders and conventional medicines remain the same after the intervention.

Detailed description

The purpose of this study is to evaluate a bundled intervention of psychotropic drugs and daily contact with a nurse for people with mental health disorders in a prayer camp and secondly to assess whether the attitudes of the prayer camp staff toward mental health disorders and conventional medicines remain the same after the intervention. In the proposed study, residents of the sanatorium at the Mount Horeb Prayer Center located in Mamfe, Ghana will be screened for psychiatric disorders by a psychiatrist. Those who are diagnosed with a psychiatric disorder requiring treatment (schizophrenia, or mood disorder) and who meet the other inclusion criteria (see below) will be randomly assigned to receive a daily dose of the appropriate psychotropic drug (according to standard procedures of care) as well as regular prayer camp treatment (intervention group) or to receive only regular prayer camp treatment (control group). After randomization, the patients in the intervention group will receive the bundled treatment for 6 weeks, while control group patients will receive regular prayer camp treatment, e.g. encouragement to pray. Psychiatrists blinded to group assignments will assess outcomes over a 6 - 8 week period. Following this, patients will be referred for continued care with health care facilities as close to their homes as possible on discharge and if they so desire. At the start of the intervention, pastors and attendants at the prayer camp will be qualitatively assessed through a semi-structured interview concerning their attributions of mental illness causation. They will be assessed -0, -6 weeks after and again -12 weeks after intervention. The investigators hypothesize that patients who receive the bundled intervention will have improved mental health outcomes and functioning and that prayer camp staff will develop more positive attitudes toward conventional medicine and will begin to conceptualize mental health disorders as treatable illnesses, rather than only as a spiritual disorder. The results will provide empirical evidence for or against an integrated model of community based care which encompasses the medical and spiritual. This is the first intervention study in Sub-Saharan Africa to promote the use of psychotropic drugs in a traditional or spiritual healing setting. Its findings may inform the implementation of national policies governing collaboration between primary health care and faith healing centers, expanding access to and improving the quality of mental health care services.

Interventions

DRUGolanzapine

oral antipsychotic drug therapy

DRUGrisperidone

oral antipsychotic drug therapy

DRUGamitryptaline

oral antidepressant drug therapy

DRUGfluoxetine

oral drug therapy for depression

Sponsors

University of Ghana Medical School
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

1. \> 18 years,\<70 2. Will benefit from treatment 3. Not suffering from physical condition 4. Resident at the prayer camp 5. Not likely to be discharged from camp within six weeks 6. Speaks either English or twi 7. Able to give consent 8. Not already on medication

Exclusion criteria

1. likely to be discharged within 6 weeks of commencement of medication 2. Patients already on medication

Design outcomes

Primary

MeasureTime frame
Brief Psychiatric Rating Scale (BPRS)6 weeks

Secondary

MeasureTime frameDescription
Clinical Global Impressions(CGI)6 weeks
Global Assessment of functioning(GAF)6 weeks
De-chaining,6 weeksThe number of days in each week that the patient was NOT restrained with physical restraints such as chains

Countries

Ghana

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 8, 2026